The Aptamer Handbook (PDF)

HISTORY AND THEORETICAL BACKGROUND In vitro selection of functional oligonucleotides and the origins of biochemical activity (J. M. Carothers and J. Szostak) Mathematical models on RNA evolution, simulations in silico, and concepts for in vitro selection (P. Schuster) Fitness landscapes, error thresholds, and cofactors in aptamer evolution (A. Kun, M. Maurel, M. Santos, E. Szathmary) IN VITRO SELECTION OF TARGET BINDING OLIGONUCLEOTIDES Aptamers to small molecules (H. Fickert, I. Fransson, U. Hahn) Aptamers to antibiotics (C. Lorenz, R. Schroeder) Aptamers to proteins (S. Nimjee, C. Rusconi, B. Sullenger) Aptamers to nucleic acid structures (J. Toulme, F. Darfeuille, C. Di Primo, E. Dausse) Natural aptamers - riboswitches (R. Welz, A. Roth, R. Breaker) IN VITRO SELECTION OF SHORT CATALYTICALLY ACTIVE OLIGONUCLEOTIDES Catalytically active RNA molecules: tools in organic chemistry (B. Weigand, A. Zerressen, J. Schlatterer, M. Helm, A. Jäschke) Deoxyribozymes: Catalytically active DNA molecules (K. Schlosser, S. McManus, Y. Li) APPLICATIONS AND OUTLOOK In vivo and in vitro target validation with nucleic acid aptamers as pharmacological probes (S. Pendergast, D. Epstein) Intramers for protein function analysis and drug discovery (M. Famulok, G. Mayer) Aptazymes: allosteric ribozymes and deoxyribozymes as biosensors (S. Knudsen, A. Ellington) Conversion of aptamer lead structures into small molecules (A. Jenne) Aptamers as ligands for affinity chromatography and capillary electrophoresis applications (E. Peyrin) Aptamers for in vivo imaging (S. Borkowski, L. Dinkelborg) Properties of therapeutic aptamers (S. Cload, T. McCauley, A. Keefe, J. Healy, C. Wilson) Spiegelmers for therapeutic applications (D. Eulberg, F. Jarosch, S. Vonhoff, S. Klussmann) Applications in the clinic: the anti-VEGF aptamer (T. Realini, E. Ng, A. Adamis) Aptamers after fifteen years (L. Gold)

Sven Klussmann is co-founder and Chief Scientific Officer of NOXXON Pharma AG, Berlin. He is a Biochemist by training and his initial studies were carried out at the Freie Universität Berlin, where he obtained his academic degrees. Dr. Klussmann received the Carl Ramsauer Award for his dissertation in which he demonstrated the principles of the Spiegelmer Technology, a new approach to identify biostable mirror-image oligonucleotides (so-called Spiegelmers) that can bind with high affinity to target molecules. He has authored more than 30 articles and 40 patents on oligonucleotides and their applications.

Dieses eBook können Sie uneingeschränkt auf allen Geräten der tolino Familie lesen. Zum Lesen auf sonstigen eReadern und am PC benötigen Sie eine Adobe ID.